Organon (OGN) Other Non-Current Liabilities (2020 - 2026)

Organon (OGN) posted quarterly Other Non-Current Liabilities of $984.0 million for Q1 2026, down 1.01% year-over-year from $994.0 million in Q1 2025, and down 2.38% on a QoQ basis from $1.0 billion in Q4 2025.

Organon (OGN) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Other Non-Current Liabilities for 7 consecutive years, with $984.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 1.01% year-over-year to $984.0 million; the TTM figure through Mar 2026 stood at $984.0 million (down 1.01% YoY), while the FY2025 annual figure was $1.0 billion, up 3.17% from the prior year.
  • Other Non-Current Liabilities came in at $984.0 million for Q1 2026 at Organon, down from $1.0 billion in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $1.1 billion in Q3 2025, with the low at $393.0 million in Q2 2023.
  • Average Other Non-Current Liabilities over 5 years is $669.3 million, with a median of $548.0 million recorded in 2024.
  • Across the five-year window, Other Non-Current Liabilities tumbled 75.42% in 2022 and soared 137.14% in 2024, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $411.0 million in 2022, then climbed by 0.24% to $412.0 million in 2023, then jumped by 137.14% to $977.0 million in 2024, then rose by 3.17% to $1.0 billion in 2025, then slipped by 2.38% to $984.0 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $984.0 million, $1.0 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 984.00 Mn
Dec 31, 2025 1.01 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.12 Bn
Mar 31, 2025 994.00 Mn
Dec 31, 2024 977.00 Mn
Sep 30, 2024 674.00 Mn
Jun 30, 2024 548.00 Mn
Mar 31, 2024 549.00 Mn
Dec 31, 2023 412.00 Mn
Sep 30, 2023 421.00 Mn
Jun 30, 2023 393.00 Mn
Mar 31, 2023 421.00 Mn
Dec 31, 2022 411.00 Mn
Sep 30, 2022 441.00 Mn
Jun 30, 2022 448.00 Mn
Mar 31, 2022 454.00 Mn
Dec 31, 2021 463.00 Mn
Sep 30, 2021 506.00 Mn
Jun 30, 2021 487.00 Mn